Thanks for the reply understood all except for the
Post# of 148109
I asked whether an eua would have an effect on our trials ability to recruit?
Your reply:
"With an EUA leronlimab would effectively be in a phase 4 trial with results coming from patients administered under the EUA."
How does a placebo arm factor into this scenario.
Thanks again for your reply